Policy & Ethicsdigital healthwearablesregulationgenerative ai
FDA Eases Guidance Spurs AI Health Innovation
|
8.4
The FDA issued new guidance classifying many wearables and health software as "low risk," and companies rapidly launched AI-powered services this month, including Utah-based Doctronic's $4 prescription refill platform and OpenAI's ChatGPT Health waitlist. Anthropic announced EHR-focused Claude features and OpenAI bought startup Torch on January 12; the guidance lowers regulatory barriers, potentially reducing costs and expanding consumer access.
Scoring Rationale
Significant FDA deregulatory shift enabling rapid AI health deployments; real-world impact limited by clinical validation and variable implementation.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
